Want to see LFST full AI Analyst Report?

Lifestance Health Group (LFST) Stock Forecast & Price Target

242 Followers

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

LFST Analyst Ratings

Strong Buy

8 Buy

2 Hold

0 Sell

Based on 10 analysts giving stock ratings to

Lifestance

Health Group

in the past 3 months

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

LFST Stock 12 Month Forecast

Average Price Target

$12.56

▲(15.19% Upside)

Based on 10 Wall Street analysts offering 12 month price targets for Lifestance Health Group in the last 3 months. The average price target is $12.56 with a high forecast of $16.00 and a low forecast of $9.00. The average price target represents a 15.19% change from the last price of $10.90.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"2":"$2","17":"$17","5.75":"$5.75","9.5":"$9.5","13.25":"$13.25"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":16,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$16.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":12.555555555555555,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$12.56</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":9,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$9.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[2,5.75,9.5,13.25,17],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Nov<br/>2025","6":"Feb<br/>2026","9":"May<br/>2026","12":"Aug<br/>2026","25":"Aug<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,10.48,10.904615384615385,11.329230769230769,11.753846153846155,12.178461538461539,12.603076923076923,13.027692307692307,13.452307692307691,13.876923076923077,14.301538461538462,14.726153846153846,15.150769230769232,15.575384615384614,{"y":16,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,10.48,10.63965811965812,10.799316239316239,10.95897435897436,11.11863247863248,11.278290598290598,11.437948717948718,11.597606837606838,11.757264957264958,11.916923076923077,12.076581196581197,12.236239316239317,12.395897435897435,{"y":12.555555555555555,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,10.48,10.366153846153846,10.252307692307692,10.138461538461538,10.024615384615386,9.910769230769231,9.796923076923077,9.683076923076923,9.569230769230769,9.455384615384615,9.341538461538462,9.227692307692308,9.113846153846154,{"y":9,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":3.79,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":5.63,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":5.45,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":4.9,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":6.41,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":7.04,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":7.18,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 14,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":7.14,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 14,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":6.37,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":7.53,"date":1777593600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":7.94,"date":1780272000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":11.43,"date":1782864000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 14,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":10.48,"date":1785542400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price Target$16.00

Average Price Target$12.56

Lowest Price Target$9.00

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts

Craig Hettenbach

Morgan Stanley

$10→$13

Buy

19.27%

Upside

Assigned

08/07/26

Morgan Stanley Reaffirms Their Buy Rating on Lifestance Health Group (LFST)

David Larsen

BTIG

$15→$16

Buy

46.79%

Upside

Reiterated

08/07/26

LifeStance price target raised to $16 from $15 at BTIGLifeStance price target raised to $16 from $15 at BTIG

Richard Close

Canaccord Genuity

$13

Buy

19.27%

Upside

Reiterated

08/06/26

LifeStance Health: Buy Rating Reaffirmed as Q2 Beat and Guidance Raise Support Unchanged $13 Price Target

Ryan Daniels

William Blair

―

Buy

―

Reiterated

08/06/26

Ryan Daniels Reiterates Buy on LifeStance Health as Strong Beat, Raised Full-Year Outlook and New $100M Buyback Underscore Improving Fundamentals

Sean Dodge

BMO Capital

$11→$13

Buy

19.27%

Upside

Assigned

08/06/26

LifeStance price target raised to $13 from $10 at BMO CapitalLifeStance price target raised to $13 from $10 at BMO Capital

Jack Slevin

Jefferies

$14

Buy

28.44%

Upside

Reiterated

07/16/26

Jefferies Sticks to Their Buy Rating for Lifestance Health Group (LFST)

Peter Warendorf

Barclays

$9→$13

Buy

19.27%

Upside

Reiterated

07/14/26

Barclays Keeps Their Buy Rating on Lifestance Health Group (LFST)

Steve Dechert

KeyBanc

$11→$13

Buy

19.27%

Upside

Reiterated

07/13/26

Lifestance Health Group (LFST) Receives a Buy from KeyBanc

Scott Fidel

Goldman Sachs

Hold

-17.43%

Downside

Initiated

06/05/26

Analyst Initiates LifeStance Health at Hold, Sets $9 Price Target Amid Execution and Margin Expansion Risks

Lisa Gill

J.P. Morgan

Hold

-17.43%

Downside

Reiterated

05/18/26

J.P. Morgan Sticks to Its Hold Rating for Lifestance Health Group (LFST)

Kevin Caliendo

UBS

$12→$13

Buy

19.27%

Upside

Reiterated

05/08/26

Analysts Offer Insights on Healthcare Companies: Mettler-Toledo (NYSE: MTD) and Lifestance Health Group (NASDAQ: LFST)

Analyst Type

Any

Human Analysts

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

Craig Hettenbach

Morgan Stanley

$10→$13

Buy

19.27%

Upside

Assigned

08/07/26

Morgan Stanley Reaffirms Their Buy Rating on Lifestance Health Group (LFST)

David Larsen

BTIG

$15→$16

Buy

46.79%

Upside

Reiterated

08/07/26

LifeStance price target raised to $16 from $15 at BTIGLifeStance price target raised to $16 from $15 at BTIG

Richard Close

Canaccord Genuity

$13

Buy

19.27%

Upside

Reiterated

08/06/26

LifeStance Health: Buy Rating Reaffirmed as Q2 Beat and Guidance Raise Support Unchanged $13 Price Target

Ryan Daniels

William Blair

―

Buy

―

Reiterated

08/06/26

Ryan Daniels Reiterates Buy on LifeStance Health as Strong Beat, Raised Full-Year Outlook and New $100M Buyback Underscore Improving Fundamentals

Sean Dodge

BMO Capital

$11→$13

Buy

19.27%

Upside

Assigned

08/06/26

LifeStance price target raised to $13 from $10 at BMO CapitalLifeStance price target raised to $13 from $10 at BMO Capital

Jack Slevin

Jefferies

$14

Buy

28.44%

Upside

Reiterated

07/16/26

Jefferies Sticks to Their Buy Rating for Lifestance Health Group (LFST)

Peter Warendorf

Barclays

$9→$13

Buy

19.27%

Upside

Reiterated

07/14/26

Barclays Keeps Their Buy Rating on Lifestance Health Group (LFST)

Steve Dechert

KeyBanc

$11→$13

Buy

19.27%

Upside

Reiterated

07/13/26

Lifestance Health Group (LFST) Receives a Buy from KeyBanc

Scott Fidel

Goldman Sachs

Hold

-17.43%

Downside

Initiated

06/05/26

Analyst Initiates LifeStance Health at Hold, Sets $9 Price Target Amid Execution and Margin Expansion Risks

Lisa Gill

J.P. Morgan

Hold

-17.43%

Downside

Reiterated

05/18/26

J.P. Morgan Sticks to Its Hold Rating for Lifestance Health Group (LFST)

Kevin Caliendo

UBS

$12→$13

Buy

19.27%

Upside

Reiterated

05/08/26

Analysts Offer Insights on Healthcare Companies: Mettler-Toledo (NYSE: MTD) and Lifestance Health Group (NASDAQ: LFST)

Stocks with the Highest Top Analyst Consensus in the Healthcare Sector

AVBPArriVent BioPharma, Inc.

BTSGBrightSpring Health Services, Inc.

AMLXAmylyx Pharmaceuticals Inc

TNYATenaya Therapeutics

JBIOJade Biosciences

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Lifestance Health Group

3 Months

Peter WarendorfBarclays

Success Rate

6/8 ratings generated profit

Average Return

+19.53%

Copying Peter Warendorf's trades and holding each position for 3 Months would result in 75.00% of your transactions generating a profit, with an average return of +19.53% per trade.

1 Year

Peter WarendorfBarclays

Success Rate

7/8 ratings generated profit

Average Return

+37.01%

Copying Peter Warendorf's trades and holding each position for 1 Year would result in 87.50% of your transactions generating a profit, with an average return of +37.01% per trade.

2 Years

Richard CloseCanaccord Genuity

Success Rate

8/9 ratings generated profit

Average Return

+69.29%

Copying Richard Close's trades and holding each position for 2 Years would result in 88.89% of your transactions generating a profit, with an average return of +69.29% per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

LFST Analyst Recommendation Trends

Rating

Apr 26

May 26

Jun 26

Jul 26

Aug 26

Strong Buy

Buy

Hold

Sell

Strong Sell

total

In the current month, LFST has received 11 Buy Ratings, 1 Hold Ratings, and 0 Sell Ratings. LFST average Analyst price target in the past 3 months is 12.56.

Each month's total comprises the sum of three months' worth of ratings.

LFST Financial Forecast

LFST Earnings Forecast

Next quarter’s earnings estimate for LFST is $0.03 with a range of $0.01 to $0.06. The previous quarter’s EPS was $0.06. LFST beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.44% of the time in the same period. In the last calendar year LFST has Performed in-line its overall industry.

LFST Sales Forecast

Next quarter’s sales forecast for LFST is $426.95M with a range of $415.60M to $436.84M. The previous quarter’s sales results were $435.35M. LFST beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.34% of the time in the same period. In the last calendar year LFST has Performed in-line its overall industry.

LFST Stock Forecast FAQ

What is LFST’s average 12-month price target, according to analysts?

Based on analyst ratings, Lifestance Health Group’s 12-month average price target is 12.56.

What is LFST’s upside potential, based on the analysts’ average price target?

Lifestance Health Group has 15.19% upside potential, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is LFST a Buy, Sell or Hold?

Lifestance Health Group has a consensus rating of Strong Buy which is based on 8 buy ratings, 2 hold ratings and 0 sell ratings.

What is Lifestance Health Group’s price target?

The average price target for Lifestance Health Group is 12.56. This is based on 10 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $16.00 ,the lowest forecast is $9.00. The average price target represents 15.19% Increase from the current price of $10.9.

What do analysts say about Lifestance Health Group?

Lifestance Health Group’s analyst rating consensus is a Strong Buy. This is based on the ratings of 10 Wall Streets Analysts.

How can I buy shares of LFST?

Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.

Lifestance Health Group (LFST) Stock Forecast & Price Target

LFST Analyst Ratings

LFST Stock 12 Month Forecast

Average Price Target

Detailed List of Analyst Forecasts​

Best Analysts Covering Lifestance Health Group

LFST Analyst Recommendation Trends

LFST Financial Forecast

LFST Earnings Forecast

LFST Sales Forecast

LFST Stock Forecast FAQ

Detailed List of Analyst Forecasts